GE Healthcare unveiled at RSNA 2009 a software technique that uses low-frequency sound waves in combination with MRI to measure the elasticity of liver tissue as an indicator of disease.
GE Healthcare unveiled at RSNA 2009 a software technique that uses low-frequency sound waves in combination with MRI to measure the elasticity of liver tissue as an indicator of disease. The technology underlying this new product, called MR-Touch, was developed at the Mayo Clinic in Rochester, MN, and licensed to GE. It extends the principles of physical palpation and MR as a way to evaluate tissue stiffness.
GE is framing MR-Touch as a precise, noninvasive and cost-effective way to detect, monitor, and understand disease. The FDA-cleared technique detects changes in the liver that indicate the presence of disease. It can also be used to monitor disease progression and provide more informed preventive guidance. Perhaps most important, the method supports a comfortable experience for the patient.
MR-Touch will be commercially available as an option to GE's newly released wide-bore 1.5T MR scanner, the Optima MR450w.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Philips Launches Flash 5100 Point-of-Care Ultrasound System
June 17th 2025Offering a combination of intuitive touchscreen controls and enhanced image clarity, the portable Flash 5100 POC ultrasound platform reportedly facilitates confident and rapid assessment in emergency radiology and critical care settings.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.